Stock A206640 BODITECH MED INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Boditech Med Inc.

Equities

A206640

KR7206640005

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 31/05/2024 am IST 		5-day change 1st Jan Change
17,650 KRW -0.06% Intraday chart for Boditech Med Inc. +7.95% -13.90%
21/02 4TEEN4 Pharmaceuticals GmbH announced that it has received funding from Boditech Med Inc. CI
2023 Boditech Med Inc. and SphingoTec GmbH Enter into Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
4TEEN4 Pharmaceuticals GmbH announced that it has received funding from Boditech Med Inc.
CI
Boditech Med Inc. and SphingoTec GmbH Enter into Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid
CI
MENARINI ANNOUNCES AN EXCLUSIVE DISTRIBUTION AGREEMENT FOR BODITECH'S AFIAS-10 SYSTEM
AQ
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 29, 2022.
CI
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 29, 2022.
CI
Boditech Med Inc.'s Equity Buyback announced on September 29, 2022, has expired with 496,620 shares, representing 2.21% for KRW 4,994.56 million
CI
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 29, 2022.
CI
Boditech Med Inc. and SphingoTec GmbH Enters into Non-Exclusive Royalty-Bearing License Agreement
CI
Boditech Med Inc. announces an Equity Buyback for KRW 5,000 million worth of its shares.
CI
Boditech Med Inc. authorizes a Buyback Plan.
CI
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on December 14, 2021.
CI
Boditech Med Inc.'s Equity Buyback announced on December 14, 2021, has expired with 297,901 shares, representing 1.31% for KRW 4,987.06 million.
CI
Novo Integrated Sciences, Boditech Med Sign Memorandum of Understanding for Distribution of Diagnostic Technologies
MT
Novo Integrated Sciences, Inc. Signs Memorandum of Understanding with Boditech Med to Market and Distribute in North America
CI
Boditech Med Announces the Formation of a U.S. Based Advisory Board and its First Member, Zachariah P. Zachariah, M.D
CI
Boditech Med Partners with Novo Integrated Sciences, Inc. to Market and Distribute Lower-Cost, Rapid Testing in North America
CI
Boditech Med to Expand to U.S., North America
CI
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on December 14, 2021.
CI
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 6, 2021.
CI
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 6, 2021.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A206640 Stock
  4. News Boditech Med Inc.